FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16646111000001101: Bazuka Treatment gel (Diomed Developments Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Mar 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2163841000001114 Bazuka Treatment gel (Diomed Developments Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2163851000001112 Bazuka Treatment gel (Diomed Developments Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bazuka Treatment gel (Diomed Developments Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Is a Product containing precisely lactic acid 40 milligram/1 gram and salicylic acid 120 milligram/1 gram conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Has active ingredient Lactic acid false Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Has specific active ingredient Lactic acid true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Is a Bazuka true Inferred relationship Existential restriction modifier
Bazuka Treatment gel (Diomed Developments Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bazuka Treatment gel (Diomed Developments Ltd) 6 gram Has AMP True Bazuka Treatment gel (Diomed Developments Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start